Are there clinical trials suitable for treating recurrent Prostate Cancer, and how can I determine if I am eligible
Yes, there are clinical trials that may be suitable for treating recurrent or advanced prostate cancer. Clinical trials are an important option to consider as they give access to new, experimental treatments before they are widely available.
According to the National Comprehensive Cancer Network (NCCN) Guidelines for Prostate Cancer, some of the clinical trial options that may be recommended for recurrent prostate cancer include:
- Trials testing new chemotherapy drugs or drug combinations
- Trials of new hormonal therapies or newer androgen receptor targeting agents
- Immunotherapy trials using vaccines or immune checkpoint inhibitors
- Trials of targeted therapies aimed at specific gene mutations
- Trials of radiopharmaceutical therapies that deliver radiation directly to cancer cells
To determine your eligibility, I would recommend speaking to your oncologist about clinical trial options. They can evaluate your specific case, cancer stage/characteristics, previous treatments, and overall health status.
Most clinical trials have strict eligibility criteria regarding cancer type, stage, prior treatment history, age, health status and more. Your oncologist can check study databases like ClinicalTrials.gov and match you to trials you may qualify for.
It's also important to understand the potential risks and benefits involved with clinical trials. While they offer access to new treatments, there may be unknown side effects. Your doctor can explain the trial details and protocols.
The American Cancer Society and cancer center websites like cancer.gov also provide resources on finding and evaluating clinical trial options that may be suited for your recurrent prostate cancer case.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for Prostate Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Prostate Cancer
- Is recurrent Prostate Cancer harder to treat than the original
- What is the role of PARP inhibitors in treating Prostate Cancer
- What is the role of radiation therapy in treating Prostate Cancer
- How do i determine the allelic frequency of my HRR SNPs
- What should I consider when choosing between clinical trial and standard treatment for Prostate Cancer
- What clinical trials for biomarkers that are specific for advanced prostate cancer that will make pluvicto more...
- Notifications of new trials: Hello, are you able to notify me about open trials and or upcoming clinical trials for...
- On the Tiffany trial for prostate cancer. Talk about that